InnovAge
INNV
$6.00
Share price
0.00%
Change (1 day)
39.53%
Change (1 year)
Categories
P/S ratio for InnovAge (INNV)
P/S ratio as of October 2023 (TTM): 1.18
According to InnovAge's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.18483. At the end of 2023 the company had a P/S ratio of 1.48.
P/S ratio history for InnovAge from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.48 | 4.63% |
| 2022 | 1.41 | 41.04% |
| 2021 | 1.00 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merck MRK | 4.46 | 276.65% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | N/A | N/A | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 8.88 | 649.52% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 7.28 | 514.81% | 🇮🇪 Ireland |